Catalent | CTLT - Pre Tax Profit


Catalent reported $-117M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.



Pre Tax Profit Change Date
Agilent USD 442M 1000K Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Bruker USD -72.6M 73.1M Sep/2025
Centene USD -6.67B 6.42B Sep/2025
Charles River Laboratories USD 170.03M 98.62M Sep/2025
Cigna USD 2.3B 274M Sep/2025
Danaher USD 1.08B 421M Sep/2025
Dentsply International USD -230M 77M Sep/2025
Elevance Health USD 215M 1.19B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Glaxosmithkline GBP 2.46B 569M Sep/2025
Hologic USD 229.7M 2.3M Dec/2025
Humana USD 527M 214M Sep/2025
Illumina USD 220M 86M Sep/2025
Intuitive Surgical USD 855.2M 23.1M Sep/2025
IQVIA Holdings USD 6.16B 5.84B Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Laboratory Of America USD 337M 32.3M Sep/2025
Lonza CHF 624M 197M Dec/2024
McKesson USD 1.4B 344M Sep/2025
Merck EUR 1.29B 458.1M Sep/2025
Merck USD 6.74B 22M Sep/2025
Mettler Toledo International USD 269.24M 20.58M Sep/2025
Novartis USD 4.2B 335M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Quest Diagnostics USD 336M 57M Sep/2025
Repligen USD 17.11M 10.25M Sep/2025
Revvity USD 55.68M 115.97M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Supernus Pharmaceuticals USD -1.91M 56.04M Dec/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
UnitedHealth USD 3.23B 1.16B Sep/2025
Veradigm USD 35.3M 94.8M Sep/2022
Waters USD 170.12M 7.57M Sep/2025
West Pharmaceutical Services USD 170.1M 8.1M Sep/2025